123 related articles for article (PubMed ID: 12505672)
1. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation.
Shapira M; Gafni M; Sarne Y
Brain Res; 2003 Jan; 960(1-2):190-200. PubMed ID: 12505672
[TBL] [Abstract][Full Text] [Related]
2. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells.
Shapira M; Gafni M; Sarne Y
Brain Res; 1998 Sep; 806(1):26-35. PubMed ID: 9739102
[TBL] [Abstract][Full Text] [Related]
3. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
Shapira M; Vogel Z; Sarne Y
Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
[TBL] [Abstract][Full Text] [Related]
4. Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
Eisinger DA; Ammer H; Schulz R
J Neurosci; 2002 Dec; 22(23):10192-200. PubMed ID: 12451120
[TBL] [Abstract][Full Text] [Related]
5. Divers pathways mediate delta-opioid receptor down regulation within the same cell.
Shapira M; Keren O; Gafni M; Sarne Y
Brain Res Mol Brain Res; 2001 Nov; 96(1-2):142-50. PubMed ID: 11731019
[TBL] [Abstract][Full Text] [Related]
6. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
[TBL] [Abstract][Full Text] [Related]
7. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
Bot G; Blake AD; Li S; Reisine T
Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
[TBL] [Abstract][Full Text] [Related]
8. Methadone-induced desensitization of the delta-opioid receptor is mediated by uncoupling of receptor from G protein.
Liu JG; Liao XP; Gong ZH; Qin BY
Eur J Pharmacol; 1999 Jun; 374(2):301-8. PubMed ID: 10422772
[TBL] [Abstract][Full Text] [Related]
9. Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists.
Marie N; Lecoq I; Jauzac P; Allouche S
J Biol Chem; 2003 Jun; 278(25):22795-804. PubMed ID: 12672796
[TBL] [Abstract][Full Text] [Related]
10. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
11. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
12. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
Traynor JR; Clark MJ; Remmers AE
J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
[TBL] [Abstract][Full Text] [Related]
13. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Rubino T; Viganò D; Massi P; Parolaro D
J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
[TBL] [Abstract][Full Text] [Related]
14. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
15. Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.
Marie N; Aguila B; Hasbi A; Davis A; Jauzac P; Allouche S
Cell Signal; 2008 Jun; 20(6):1209-20. PubMed ID: 18395423
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
Szekeres PG; Traynor JR
J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
[TBL] [Abstract][Full Text] [Related]
19. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
[TBL] [Abstract][Full Text] [Related]
20. Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction.
Howlett AC; Wilken GH; Pigg JJ; Houston DB; Lan R; Liu Q; Makriyannis A
J Neurochem; 2000 May; 74(5):2174-81. PubMed ID: 10800963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
